Amanta Healthcare IPO | The public will be able to subscribe for the Rs 126-crore IPO, which is a completely new offering of one crore shares, starting on September 1 and ending on September 3.
Amanta Healthcare Raises ₹37.8 Crore from Anchor Investors Ahead of ₹126-Crore IPO
Before its subscription period opened on August 29, Amanta Healthcare, a pharmaceutical business that specializes in producing parenteral pharmaceuticals, received Rs 37.8 crore from six institutional investors through an anchor book.
The Rs 126-crore IPO, which consists of entirely fresh issue of 1 crore shares, will open for public subscription on September 1 and close on September 3.
The company, in its filing to exchanges on Friday, said it has finalised allocation of 30 lakh shares to anchor investors at Rs 126 per share.
Out of the total allocation of 30 lakh shares, 7.93 lakh shares were allocated to Bandhan Mutual Fund which applied through its Small Cap Fund.
Other institutional investors that took part in the anchor book were Sunrise Investment Trust, Finavenue Capital Trust, Perpetuity Health to Wealth Rising Fund, and Sanshi Fund.
Amanta Healthcare, which aims for a value of about Rs 500 crore, plans to use Rs 70 crore of the IPO proceeds to establish a new SteriPort manufacturing line and Rs 30.13 crore to establish a new small volume parenteral (SVP) production line in Hariyala, Gujarat. The remaining money will be reserved for basic business needs.
For the Amanta Healthcare IPO, Beeline Capital Advisors is serving as the only book running lead manager.
AQ on Amanta Healthcare IPO (September 2025)
Q1. What is the Amanta Healthcare IPO issue size?
The IPO is worth ₹126 crore, consisting of a fresh issue of 1 crore equity shares.
Q2. When will the Amanta Healthcare IPO open and close?
The IPO opens on September 1, 2025, and closes on September 3, 2025.
Q3. What is the price band for the Amanta Healthcare IPO?
The company has fixed the IPO price at ₹126 per share.
Q4. What is Amanta Healthcare’s IPO lot size?
The lot size details will be available in the IPO prospectus, typically set for retail investors to bid in multiples.
Q5. When will the Amanta Healthcare IPO allotment be finalized?
The IPO share allotment will be finalized on September 4, 2025.
Q6. When will Amanta Healthcare shares be listed on stock exchanges?
The shares will list on the bourses (likely NSE and BSE) on September 9, 2025.
Q7. How much did Amanta Healthcare raise from anchor investors?
The company raised ₹37.8 crore from six institutional investors on August 29, 2025, via the anchor book.
Q8. Which anchor investors participated in Amanta Healthcare IPO?
Notable participants include Bandhan Mutual Fund (Small Cap Fund), Sunrise Investment Trust, Finavenue Capital Trust, Perpetuity Health to Wealth Rising Fund, and Sanshi Fund.
Q9. How many shares were allotted to anchor investors?
A total of 30 lakh shares were allocated to anchor investors at ₹126 per share.
Q10. What does Amanta Healthcare do?
Amanta Healthcare is a pharmaceutical company specializing in sterile liquid products and parenteral drugs.
Q11. Where is Amanta Healthcare located?
The company has operations in Hariyala, Gujarat, where it plans new production facilities.
Q12. What will the company use IPO proceeds for?
₹70 crore: Establishing a new SteriPort manufacturing line
₹30.13 crore: Setting up a new Small Volume Parenteral (SVP) production line in Gujarat
Balance: General corporate purposes
Q13. What is Amanta Healthcare’s valuation target post IPO?
The company is aiming for a market value of around ₹500 crore.
Q14. Who is the lead manager for Amanta Healthcare IPO?
Beeline Capital Advisors is the sole book-running lead manager.
Q15. What is Amanta Healthcare’s business strength?
The company is well-known in the parenteral pharmaceutical segment, producing sterile injectables used in hospitals and healthcare facilities.
Q16. Is Amanta Healthcare IPO a fresh issue or an offer for sale (OFS)?
It is a 100% fresh issue — no existing shareholder is selling their stake.
Q17. What segment of investors can apply for Amanta Healthcare IPO?
The IPO is open to Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs/HNIs), and Retail Investors.
Q18. How can retail investors apply for the IPO?
Retail investors can apply via UPI through ASBA (Application Supported by Blocked Amount) using their bank or broker platforms.
Q19. What is the minimum investment required in Amanta Healthcare IPO?
The minimum investment will depend on the lot size, which is set in the prospectus. At ₹126 per share, the minimum outlay will be calculated accordingly.
Q20. What are the risks of investing in Amanta Healthcare IPO?
Heavy dependence on parenteral segment
Regulatory compliance in pharma manufacturing
Competition from established pharma players
Execution risk in setting up new plants
Q21. What are the opportunities for Amanta Healthcare post-IPO?
Expansion into SteriPort and SVP production
Growing demand for sterile injectables in India and exports
Enhanced capacity for hospital supply contracts
Q22. Can NRIs apply for Amanta Healthcare IPO?
Yes, subject to RBI regulations, NRIs can invest in the IPO through NRE/NRO accounts.
Q23. How can investors check Amanta Healthcare IPO allotment status?
Investors can check IPO allotment on the registrar’s website, the stock exchanges (NSE/BSE), or through their brokers.
Q24. How soon will refunds or unblocking of funds happen post-allotment?
Refunds/unblocking of funds will take place by September 5–6, 2025, after allotment finalization.
Q25. Will Amanta Healthcare IPO be listed on NSE and BSE?
Yes, the company plans to list its equity shares on both NSE and BSE.
